An independent consultant in the medical device segment with over 25 years in the healthcare industry. Previously, she was a co-Founder, Director, and President of TrueMotion Spine (a seed-stage medical device company), President of Synogen, Inc. (a private equity venture fund), and Co-founder and VP of Corporate Development at Xhale, Inc. a medical device company recently acquired by Philips Healthcare. She has also participated as a key management team member in the launch and growth of several high-tech start-up companies. Ms. Warrington also served as Chairman of BioFlorida. Ms. Warrington obtained her BS in Business Administration, MBA. and MHA all from the University of Florida.
Vice President, Market Development for VIR Biotechnology in San Francisco. Previously she was Global Commercial Leader, New Product Planning for Ultragenyx Pharmaceuticals and prior to that; Chief Operating Officer for OBMedical Company. Previously she held several management positions with Genentech, Chiron Corporation/Novartis, and other life science therapeutic and medical device companies. Early in her career, she was a consultant with Boston Consulting Group. Ms. Jhaveri received an MBA from Harvard University, a masters in economic development from the University of Sussex, and a BA with honors from Stanford.
Co-founder of De Novo Ventures, one of the premier firms dedicated to medical devices and biotechnology with $650 million under management. Mr. Ferrari has raised over a billion dollars for companies he has directly influenced and participated in approximately $1.5 billion in acquisition events. Additionally, he has been a successful CEO of two publicly traded medical technology companies including Cardiovascular Imaging Systems, the first and leading developer of ultrasound imaging catheters which was eventually acquired for $125 million by Boston Scientific, and CardioThoracic Systems (CTS), the market leader in disposable instruments and systems for performing minimally invasive beating heart bypass surgery, which was acquired by Guidant for $350 million. Mr. Ferrari is the recipient of the Mallinckrodt Award for Excellence in Medicine and has been a finalist for the Entrepreneur of the Year Award. He holds a BS degree from Ashland University and an MBA from the University of South Florida.